These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 7243492)

  • 1. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
    Pullarkat RK; Reha H; Beratis NG
    Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
    Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
    Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry.
    Gu J; Tifft CJ; Soldin SJ
    Clin Biochem; 2008 Apr; 41(6):413-7. PubMed ID: 18241673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis of congenital lipidoses by lipid analyses of body fluids, biopsy and autopsy tissue].
    Pilz H; Heipertz R
    Fortschr Neurol Psychiatr Grenzgeb; 1975 Nov; 43(11):602-17. PubMed ID: 53174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma G
    Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
    Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S; Krusell A; Lyerla TA; Bremer EG; Kolodny EH
    Biochim Biophys Acta; 1985 Apr; 834(2):238-48. PubMed ID: 3995063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS; Krasnopol'skaia KD
    Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM; Brooks SE; Amsterdam D; Oropello J; Schneck L
    J Neurosci Res; 1980; 5(5):413-7. PubMed ID: 7441795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
    Neuenhofer S; Conzelmann E; Schwarzmann G; Egge H; Sandhoff K
    Biol Chem Hoppe Seyler; 1986 Mar; 367(3):241-4. PubMed ID: 3707714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
    Akhunov VS; Mirenburg TV; Krasnopolskaya XD
    J Inherit Metab Dis; 1994; 17(1):104-11. PubMed ID: 8051915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
    Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V
    J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization.
    Banerjee A; Burg J; Conzelmann E; Carroll M; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1984 Mar; 365(3):347-56. PubMed ID: 6724528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of GM2-gangliosidosis B1 variant.
    Lemos M; Pinto R; Ribeiro G; Ribeiro H; Lopes L; Sá Miranda MC
    Prenat Diagn; 1995 Jun; 15(6):585-8. PubMed ID: 7659693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid.
    Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.
    Sonderfeld S; Conzelmann E; Schwarzmann G; Burg J; Hinrichs U; Sandhoff K
    Eur J Biochem; 1985 Jun; 149(2):247-55. PubMed ID: 3922757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.